Sushma Dharani

Are you ready to transform how DSURs and PADERs are generated in pharmacovigilance? Manual, time-consuming reporting processes are no longer sustainable as safety data volumes and regulatory expectations grow. Automated DSUR and PADER generation enables faster submissions, improved data accuracy, and stronger compliance. With intelligent automation and domain expertise, Tesserblu helps PV teams streamline aggregate reporting and shift focus from manual effort to meaningful safety insights.

A slow literature review in pharmacovigilance creates hidden opportunity costs. Delayed identification of safety data can postpone signal detection, increase regulatory risk, and prolong patient exposure to emerging risks. Manual processes also consume skilled PV resources, limiting focus on higher-value activities like signal evaluation and risk management. Platforms like Tesserblu help accelerate reviews, improve consistency, and unlock greater value from scientific literature.

New product launches are faster and more complex than ever, placing unprecedented pressure on pharmacovigilance teams. Traditional PV processes often struggle to keep pace with accelerated approvals, global launches, and rapidly evolving safety data. An agile, digitally enabled PV model is now essential to ensure compliance, detect signals early, and protect patient safety from day one of launch.